Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


Highlights from the iwCLL 2019 in Edinburgh

The 18th International Workshop on CLL (iwCLL) will take place in Auld Reekie - as Edinburgh used to be called by the Scots - from 20 to 23 September. Are you unable to attend this congress? No worries, MEDtalks will travel to this historic city to bring you the most important news about chronic lymphocytic leukemia (CLL).

What news is told about diagnostic tests on CLL? And what are the recommendations for the treatment of patients in the frontline and later lines? Renowned hematologists/researchers will talk about this and more in a series of interviews that can be viewed on our website from the beginning of October.

Interviews

Diagnostic tests

  • Prof. Richard Rosenquist, MD - hematologist, Karolinska University Hospital, Stockholm, Sweden. 
  • Andy Rawstron, MD, PhD - clinical researcher, St. James Institute of Oncology, Leeds, UK. 

CLL immunogenetics and B-cell receptor stereotypes

  • Dr. Kostas Stamatopoulos - physician-scientist, Institute of Applied Forest Sciences CERTH, Thessaloniki, Greece. 

 The role of NOTCH1 and Richter’s transformation

  • Silvia Deaglio, MD, PhD - oncologist, University of Turin, Italy. 

Frontline treatment

What are the recommendations for frontline treatment of CLL? 

  • Valentin Goede, MD, hematologist at St. Marien-Hospital in Cologne (Germany), discusses frontline treatment in young and older CLL patients.

  • Prof. Paolo Ghia, MD, medical oncologist at Vita-Salute San Raffaele University in Milan (Italy), catches up on the use of biomarkers to choose the right treatment.

  • Prof. Dominique Bron, MD, hematologist at Jules Bordet Institute in Brussels (Belgium), gives her vision on how to make a choice in frontline CLL treatment. 

Relapse treatment

  • Prof. John Seymour, MD - hematologist, Peter MacCallum Cancer Centre, Melbourne, Australia. 

  • Talha Munir, MD, PhD - hematologist, St James’s Hospital, Leeds, UK. 

 Future treatment of CLL

  • Prof. Anna Schuh, MD, hematologist at the University of Oxford (UK), talks about future management of CLL. 

  • David Maloney, MD, PhD, hematologist at the Fred Hutchinson Cancer Research Center in Seattle (USA), talks about CAR-t cell therapy in CLL. 

By registering you gain access to the interviews.

  • Sponsors

    This program is editorially independent and is financially supported by:

Related items